| __timestamp | ADMA Biologics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 24518692 |
| Thursday, January 1, 2015 | 6745968 | 19886580 |
| Friday, January 1, 2016 | 8494742 | 12631689 |
| Sunday, January 1, 2017 | 18092835 | 21977998 |
| Monday, January 1, 2018 | 22502922 | 20759000 |
| Tuesday, January 1, 2019 | 25910757 | 20838000 |
| Wednesday, January 1, 2020 | 35050817 | 121812000 |
| Friday, January 1, 2021 | 42896889 | 152137000 |
| Saturday, January 1, 2022 | 52458024 | 83231000 |
| Sunday, January 1, 2023 | 59020000 | 122706000 |
Unleashing the power of data
In the competitive landscape of biotechnology, understanding the financial strategies of key players is crucial. Over the past decade, TG Therapeutics, Inc. and ADMA Biologics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, TG Therapeutics consistently outpaced ADMA Biologics, with its SG&A expenses peaking at approximately 152 million in 2021, a staggering 150% increase from 2014. In contrast, ADMA Biologics saw a steady rise, culminating in a 2023 figure that was nearly 12 times its 2014 expenses. This divergence highlights TG Therapeutics' aggressive expansion strategy, while ADMA Biologics appears to be adopting a more measured approach. As these companies continue to evolve, their financial strategies will undoubtedly play a pivotal role in shaping their future trajectories.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
TG Therapeutics, Inc. vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited